The neurobiology of autism: New pieces of the puzzle

被引:34
作者
Maria T. Acosta
Phillip L. Pearl
机构
[1] Department of Neurology, Children's National Medical Center, Washington, DC 20010-2970
关键词
Autistic Disorder; Rett Syndrome; Brain Growth; Acad Child Adolesc Psychiatry; Autistic Individual;
D O I
10.1007/s11910-003-0067-0
中图分类号
学科分类号
摘要
The neurobiologic basis of autism is reviewed, with discussion of evidence from genetic, magnetic resonance imaging, neuropathology, and functional neuroimaging studies. Although autism is a behaviorally valid syndrome, it is remarkably heterogeneous and involves multiple developmental domains as well as a wide range of cognitive, language, and socioemotional functioning. Although multiple etiologies are implicated, recent advances have identified common themes in pathophysiology. Genetic factors play a primary role, based on evidence from family studies, identification of putative genes using genome-wide linkage analyses, and comorbidities with known genetic mutations. The RELN gene, which codes for an extracellular protein guiding neuronal migration, has been implicated in autism. Numerous neuropathologic changes have been described, including macroencephaly, acceleration and then deceleration in brain growth, increased neuronal packing and decreased cell size in the limbic system, and decreased Purkinje cell number in the cerebellum. Abnormalities in organization of the cortical minicolumn, representing the fundamental subunit of vertical cortical organization, may underlie the pathology of autism and result in altered thalamocortical connections, cortical disinhibition, and dysfunction of the arousal-modulating system of the brain. The role of acquired factors is speculative, with insufficient evidence to link the measles-mumps-rubella (MMR) vaccine with autism or to change immunization practices. Copyright © 2003 by Current Science Inc.
引用
收藏
页码:149 / 156
页数:7
相关论文
共 102 条
[71]  
Casanova M.F., Buxhoeveden D.P., Cohen M., Et al., Minicolumnar pathology in dyslexia, Ann. Neurol., 52, pp. 108-110, (2002)
[72]  
Pickett J., Current investigations in autism brain tissue research, J. Autism Dev. Disord., 31, pp. 521-527, (2001)
[73]  
Blatt G.J., Fitzgerald C.M., Guptill J.T., Et al., Density and distribution of hippocampal neurotransmitter receptors in autism: An autoradiographic study, J. Autism Dev. Disord., 31, pp. 537-543, (2001)
[74]  
Junaid M.A., Pullarkat R.K., Proteomic approach for the elucidation of biological defects in autism, J. Autism Dev. Disord., 31, pp. 557-560, (2001)
[75]  
Whitaker-Azmitia P.M., Serotonin and brain development: Role in human developmental diseases, Brain Res. Bull., 56, pp. 479-485, (2001)
[76]  
Barreto Medeiros J.M., Cabral Filho J.E., De Souza S.L., Et al., Early malnourished rats are not affected by anorexia induced by a selective serotonin reuptake inhibitor in adult life, Nutr. Neurosci., 5, pp. 211-214, (2002)
[77]  
Chugani D.C., Muzik O., Behen M., Et al., Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children, Ann. Neurol., 45, pp. 287-295, (1999)
[78]  
Tordjman S., Gutknecht L., Carlier M., Et al., Role of the serotonin transporter gene in the behavioral expression of autism, Mol. Psychiatry, 6, pp. 434-439, (2001)
[79]  
Carlsson M.L., Hypothesis: Is infantile autism a hypoglutamatergic disorder? Relevance of glutamate-serotonin interactions for pharmacotherapy, J. Neural Transm., 105, pp. 525-535, (1998)
[80]  
Donovan S.L., Mamounas L.A., Andrews A.M., Et al., GAP-43 is critical for normal development of the serotonergic innervation in forebrain, J. Neurosci., 22, pp. 3543-3552, (2002)